Farmak’s specialists have developed and began marketing Betaspan, a corticosteroid drug. The new medication is produced in the form of solution for injection.
Betaspan is intended for concomitant therapy of endocrine diseases, critical conditions involving suprarenal failure, inflammatory and degenerative diseases of the musculoskeletal system, rheumatologic diseases, in ophthalmology and oncology. The drug has anti-shock, antitoxic, anti-inflammatory, and immunosuppressive effect.
Betaspan is produced in the form of solution for injection, with 5 ampoules per package.
